Home
Scholarly Works
Angiagenesis pathway gene polymorphisms associated...
Conference

Angiagenesis pathway gene polymorphisms associated with clinical outcome in recurrent ovarian cancer treated with low dose cyclophosphamide and bevacizumab: A California Consortium Trial.

Authors

Schultheis AM; Yang D; Garcia AA; Morgan R; Gandara D; Scudder S; Oza A; Hirte H; Fleming G; Roman L

Volume

24

Pagination

pp. 260S-260S

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

June 20, 2006

Name of conference

42nd Annual Meeting of the American-Society-of-Clinical-Oncology

Conference place

GA, Atlanta

Conference start date

June 2, 2006

Conference end date

June 6, 2006

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

18

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team